In a study presented at MDS 2021, researchers assessed whether patients with tic disorders with or without major psychoses were at risk of developing tardive dyskinesia.
At MDS 2021, researchers shared study results on the effect of Parkinson disease (PD)-related genes on the risk for cardiovascular events among patients with genetic forms of PD, including those with variations in the LRRK2 and GBA genes.
At MDS 2021, researchers shared results of a genetics investigative analysis on variations in the BSN gene in patients with multiple system atrophy.
In a systematic review and network meta-analysis presented at MDS 2021, researchers assessed the effect of device-aided strategies on off-time improvement and quality of life in Parkinson disease.
In a phase 3 trial presented at MDS 2021, researchers evaluated the efficacy and safety of DaxibotulinumtoxinA for Injection in the treatment of cervical dystonia in adults.
Researchers observed the differences in the effect of COVID-19 stressors on mental health and quality of life in subgroups of patients with Parkinson disease.
At MDS 2021, researchers reported on the brainstem structural connectivity changes in patients with REM sleep behavior disorder using an in-vivo probabilistic brainstem nuclei atlas and 7 Telsa MRI.
Researchers assessed the features of Parkinson disease (PD) pathophysiology that may increase the risk for COVID-19 mortality among hospitalized patients with PD.
A researcher assessed the predictive power of neuropsychologic features in distinguishing the progression to Alzheimer disease vs Lewy body dementia in patients with mild cognitive impairment.
Researchers analyzed brain MRI characteristics of patients with Huntington disease and related them to the major manifesting symptoms at clinical onset.
Researchers shared their findings on the cerebrospinal fluid profile of patients with fragile X-associated tremor/ataxia syndrome and potential biomarkers.
In a poster presented at MDS 2021 and as part 2 of the MOVES-PD trial, researchers assessed the safety and efficacy of venglustat, a glucosylceramide synthase inhibitor, in patients stratified by GBA gene variation severity.
At an abstract presented at MDS 2021, researchers described and analyzed eye movements in patients with an inborn errors of metabolism and their presence in early disease.
Researchers assessed the impact of specialized light therapy on motor and nonmotor symptoms in patients with Parkinson disease.
In a study presented at MDS 2021, researchers assessed the long-term safety and activity of ecopipam, a selective D1 antagonist, in reducing tics in children with Tourette syndrome.